MDLN Medline Inc. Class A common stock

XNAS 39.68 Delayed
Find condors

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Expected move IV rank history Fibonacci levels Insider trading

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

MDLN $39.68 —
Key stats
$39.68
52-Week Range
$31.37 – $50.88
YTD
-2.32%
IV Rank (30D)
15.84
Straddle Price
$4.40
P/C Vol Ratio
1.94
Market Cap
$34.9B
Open
$39.53
Day Range
$38.31 – $39.86
Volume
3,928,040
Prev Close
$39.76
Fair Value
MODEL: SHORT

A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.

  • DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
  • Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
  • DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
  • P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
  • Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
  • Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
  • Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
  • Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
10-yr Treasury (rf)4.95%
Beta vs SPY0.52
Cost of Equity (CAPM)7.57% (VRP-adj)
WACC7.93%
Volatility Risk Premium+7.4pp (IV − HV30)
Effective Tax Rate19.7%
Rev. Growth (YoY, DCF input)+3.0%
DCF Horizon5 years explicit + fade
Forward Tilt (NTM/TTM)×1.03 (applied to P/E, EV/EBITDA, P/S)
Return on Equity (TTM)4.5%
Book / Price76.9% — banking bias active (P/B is primary)
Gross Margin (TTM)27.2%
Debt / Equity0.66
Quality Score0/6 — cyclical/struggling (5y DCF)
SMA 50$34.68 (Market Anchor value)
SMA 20 / Bollinger Mid$35.08
Bollinger Width / SMA2070.8% (drives anchor stability)
Net Debt$10.2B
Market Cap$25B
Peers used for multiples: ABT, HUM, MDT (filtered from 8 ETF-co-members; sector bias active)
60-Day Conviction
33%
20-Day Fair Value
≈ by Dec 7, 2026
$39.84
α +0.1% rank 97%
conviction
6%
40-Day Fair Value
≈ by Jan 5, 2027
$40.18
α +0.9% rank 97%
conviction
29%
60-Day Fair Value
≈ by Feb 3, 2027
$39.48
α -0.8% rank 97%
conviction
33%
MethodImplied PriceWeightDetail
DCF n/a 0%
DDM (Gordon) n/a 0%
Peer P/E n/a 0% median 36.8× · 3 peers
Peer EV/EBITDA $55.02 17% median 19.5× · 3 peers
Peer P/B $81.65 22% median 2.7× · 3 peers
Peer P/S $129.58 22% median 3.6× · 3 peers
Market Anchor (SMA50) $34.68 0% stability 0% (BB-width)
Options Expected (B-L 30d) $39.83 39% 14 strikes · skew +0.17
As of 2026-11-06 · updated
About
Industry (SIC)
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS (3841) · industry map
Exchange
XNAS
Market Cap
$34.9B
Employees
45,000
List Date
2025-12-17
CIK
0002046386
Headquarters
Northfield, IL
Homepage
https://www.medline.com

Medline is the largest provider of medical-surgical products and supply chain solutions in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front-line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their …

Summary
—
composite
—
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart
Seasonality
'25'26Avg
Jan--8.81%8.81%
Feb--5.53%5.53%
Mar---2.94%-2.94%
Apr--1.07%1.07%
May---18.30%-18.30%
Jun--10.32%10.32%
Jul---5.55%-5.55%
Aug---13.44%-13.44%
Sep---1.17%-1.17%
Oct---8.07%-8.07%
Nov--18.38%*18.38%
Dec2.44%--2.44%
Total2.44%-10.73%-4.14%
* Only 2 year(s) of data available.
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $35.25
SMA 50: $34.78
SMA 200: $39.48
Current: $39.79
EMA 12: $36.16
EMA 26: $35.41
MACD: 0.7446 | Signal: 0.7027
BULLISH
ADX (14): 23.37
WEAK TREND
+DI: 41.12
−DI: 15.78

Momentum Oscillators

RSI (14): 69.88
NEUTRAL
Stoch %K: 86.52
Stoch %D: 74.24
Williams %R: -17.69

Volume & Volatility

BB Upper: $40.05
BB Lower: $30.46
NEUTRAL
OBV: -30,611,237
Vol SMA 20: 10,030,835
Vol ROC: -47.25%
ATR: $1.66
True Range: $1.55
HV 20: 67.6%
HV 30: 55.3%
HV 60: 49.6%

Data Summary

Data Points: 223
Last Updated:
Date Range: 2025-12-17T00:00:00 – 2026-11-05T00:00:00
AI Analysis

LLM Stock Analysis Report

Executive Summary

Overall assessment: BEARISH with confidence level (6/10)

Key drivers: Negative news sentiment, technical indicators suggesting downtrend, low volatility

Primary risks: Regulatory issues, manufacturing violations, failed contamination investigations

Investment thesis: Medline Inc. (MDLN) is experiencing a near-term headwind due to recent negative news and a potential decline in stock price.

Recent news sentiment impact: The negative news headlines have contributed to the bearish momentum, with investors becoming increasingly cautious about the company's prospects.

Technical Analysis

Trend Direction: Short-term (1-4 weeks) - BEARISH, Medium-term (1-3 months) - NEUTRAL, Long-term (3-12 months) - NEUTRAL

Support/Resistance Levels: Lower Bollinger Band ($31.10), 20-day SMA ($35.66)

Momentum Signals:

  • RSI interpretation: Neutral (44.23)
  • MACD signal: Bearish (-1.06 / Signal: 0.07 / Histogram: -1.13)
  • Bollinger Bands position: Squeeze

Volume Analysis: Volume is trending downward, with a Volume Rate of Change of -13.25%. On-Balance Volume (OBV) is also negative.

News & Sentiment Analysis

Recent Headlines Summary: Recent news headlines have been overwhelmingly negative, highlighting regulatory issues, manufacturing violations, and failed contamination investigations.

Sentiment Assessment: Aggregate news sentiment is NEGATIVE, with 5 out of 6 recent headlines conveying bearish sentiment.

Catalyst Identification: The company's recent secondary offering and potential earnings reports may provide catalysts for future price movements.

Market Narrative: The negative news has contributed to a decline in stock price, which may create an opportunity for investors to enter at a lower price level.

Risk & Volatility Assessment

Beta Interpretation: Beta is 0.59 (vs SPY), indicating low volatility and a relatively stable market presence.

Volatility Regime: Historical volatility levels are moderate (HV20 67.8%, HV30 59.9%), with the IV Premium vs HV30 at 10.6% (positive).

Options Market Signals: Options market is pricing $2.55 move by expiration, indicating relatively low implied volatility.

Downside Protection: Lower Bollinger Band ($31.10) provides support in case of a further decline in stock price.

Market Context & Positioning

Sector Performance: Medline Inc.'s sector (Healthcare Supplies) is performing relatively well, with the Healthcare Select Sector SPDR Fund (XLV) up 2.5% over the past month.

Institutional Activity: Institutional interest is moderate, with a Volume Rate of Change of -13.25%.

Correlation Analysis: Medline Inc.'s stock moves relatively less than the broader market (R-squared = 0.17), indicating low correlation.

Relative Valuation: The company's relative valuation suggests it may be slightly undervalued within its trading range.

Key Levels & Action Items

Critical Price Levels: Lower Bollinger Band ($31.10) and 20-day SMA ($35.66)

Breakout/Breakdown Levels: Break below the lower Bollinger Band could indicate a more significant decline in stock price, while a breakout above the 20-day SMA could signal a potential rebound.

Time-Sensitive Catalysts: The company's recent secondary offering and potential earnings reports may provide catalysts for future price movements.

Risk Management: A stop-loss level of $32.50 could be considered to mitigate potential losses in case of further decline in stock price.

Please note that this analysis is based on the provided data, and actual market performance may differ.

Generated
Earnings History
3 of 4 under expected move
Avg Expected Move
12.24%
Avg Actual Move
10.52%
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2026-02-25 Pre-Market 12.60% 3.62% 0.29x Within
2026-05-06 Pre-Market 10.81% 7.30% 0.68x Within
2026-08-05 Pre-Market 13.68% 12.79% 0.93x Within
2026-11-04 Pre-Market 11.88% 18.36% 1.55x Exceeded

Earnings calendar: this week’s reports with expected vs actual moves →

MDLN Options Activity & IV Rank

MDLN IV rank history, 52-week IV rank and IV percentile →

Volatility Metrics

Current IV: 41.3%
7-DTE IV: 43.3%
Expected Move: $4.40
7-DTE Move: $2.72
Days to Exp: 42 (2026-12-18)

Options Flow

Call Volume: 103
Put Volume: 200
P/C Volume: 1.942
BEARISH
Call OI: 276
Put OI: 216
P/C OI: 0.783
Total OI: 492

ATM Options Pricing

ATM Call: $2.10
ATM Put: $2.30
Call %: 5.3%
Put %: 5.8%

Chain Summary

Chain Volume: 10,241
Chain OI: 65,134
Last Updated: 11/6/2026
Spread Scanner GPU
Full Algorithm Docs ↗

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Dealer Positioning
HIGH γ vs HISTORY

Estimated net dealer gamma is at the 85th percentile of this name's own daily history, near the high end of its range. This describes current positioning; it is not a forecast or a trading signal.

Gamma percentile
85%
vs own history
GEX tilt
+0.83
OI-weighted, today
Vanna tilt
+0.78
δ-sensitivity to IV
Charm tilt
-0.78
δ-decay vs time
Vanna tilt +0.78: the estimated dealer exposure leans positive, so the modeled hedge would shift noticeably if implied volatility changed.
Charm tilt -0.78: the estimated dealer exposure leans negative, so the modeled hedge would shift noticeably as time passes and options approach expiry.

Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.

Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.

Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.

This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.

· 31 ATM contracts, 37k total OI
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Wing vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together

Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d 0%
+5.0 pts EXTREME
ATM 42.5% / Wing 47.5%
30 DTE / 10d —
— pts EXTREME
No data

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Enter a ticker to render the implied volatility surface.

Volatility Smile

Enter a ticker to render the implied volatility smile.

IV Rank (7 DTE)16.5LowNov 6
IV Rank (30 DTE)15.8LowNov 6
Straddle Price (30 DTE)$4.40Nov 6
Beta Analysis

Risk Metrics

Beta: 0.6914
Alpha: -0.10%
Correlation: 0.1974
R-Squared: 3.9%
Stock Volatility: 47.9%
Market Volatility: 13.7%

Analysis Details

Benchmark: SPY
Data Points: 223
Period: 252 trading days
Interpretation:
Low volatility - stock moves less than market
Beta & Alpha Over Time

MDLN Institutional Ownership (13F)

Latest filings — 2026-09-30
Diluted shares outstanding: 623,854,158 (as of 2026-06-27)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

427 filers779,452,980 shares$30.73B value124.94% of float
# Filer Shares Value % of Total % of Float Period
1 Carlyle Group Inc. 187,083,713 $7.38B 24.01% 29.99% 2026-06-30
2 H&F Corporate Investors X, Ltd. 70,874,326 $2.80B 9.10% 11.36% 2026-06-30
3 FMR LLC Custodian 46,963,203 $1.85B 6.03% 7.53% 2026-06-30
4 Capital Research Global Investors 39,963,790 $1.58B 5.13% 6.41% 2026-06-30
5 Invesco Ltd. Custodian 38,346,937 $1.51B 4.92% 6.15% 2026-06-30
6 BlackRock, Inc. Custodian 26,393,587 $1.04B 3.39% 4.23% 2026-06-30
7 Morgan Stanley Custodian 21,605,662 $852.13M 2.77% 3.46% 2026-06-30
8 LONE PINE CAPITAL LLC 20,968,367 $826.99M 2.69% 3.36% 2026-06-30
9 Vanguard Group Inc Custodian 18,887,568 $793.28M 2.58% 3.03% 2025-12-31
10 Massachusetts Financial Services Co 19,888,806 $787.12M 2.56% 3.19% 2026-06-30
11 Vanguard Capital Management LLC 17,816,057 $702.67M 2.29% 2.86% 2026-06-30
12 Vanguard Portfolio Management LLC 16,781,031 $661.84M 2.15% 2.69% 2026-06-30
13 Jupiter Topco LLC 15,858,400 $625.44M 2.04% 2.54% 2026-06-30
14 Janus Henderson Group plc 11,451,861 $506.55M 1.65% 1.84% 2026-03-31
15 DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main 11,956,905 $471.58M 1.53% 1.92% 2026-06-30
16 Egerton Capital (UK) LLP 13,283,017 $460.92M 1.50% 2.13% 2026-09-30
17 BAILLIE GIFFORD & CO 11,343,036 $447.37M 1.46% 1.82% 2026-06-30
18 Norges Bank 8,475,413 $334.27M 1.09% 1.36% 2026-06-30
19 State Street Corp 8,447,035 $333.15M 1.08% 1.35% 2026-06-30
20 Geode Capital Management, LLC Custodian 7,948,506 $312.74M 1.02% 1.27% 2026-06-30
21 SurgoCap Partners LP 7,487,507 $295.31M 0.96% 1.20% 2026-06-30
22 WCM INVESTMENT MANAGEMENT, LLC 7,397,650 $293.02M 0.95% 1.19% 2026-06-30
23 HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 7,355,574 $290.10M 0.94% 1.18% 2026-06-30
24 Alyeska Investment Group, L.P. 6,809,122 $268.55M 0.87% 1.09% 2026-06-30
25 BANQUE PICTET & CIE SA 7,455,089 $258.69M 0.84% 1.20% 2026-09-30
9 filers$58.73M notional
# Filer Notional Value % of Total Period
1 Susquehanna International Group, LLP Custodian $19.97M 34.01% 2026-06-30
2 CREDIT AGRICOLE S A $18.62M 31.70% 2026-06-30
3 Citadel Advisors LLC Custodian $7.87M 13.40% 2026-06-30
4 IMC-Chicago, LLC Custodian $4.48M 7.64% 2026-06-30
5 Simplex Trading, LLC Custodian $3.25M 5.53% 2026-06-30
6 Jane Street Group, LLC Custodian $2.61M 4.44% 2026-06-30
7 GROUP ONE TRADING LLC Custodian $832.18K 1.42% 2026-06-30
8 Pentwater Capital Management LP $788.80K 1.34% 2026-06-30
9 Millennium Management LLC Custodian $311.58K 0.53% 2026-06-30
10 filers$88.96M notional
# Filer Notional Value % of Total Period
1 Caption Management, LLC $27.61M 31.04% 2026-06-30
2 Susquehanna International Group, LLP Custodian $15.64M 17.58% 2026-06-30
3 GROUP ONE TRADING LLC Custodian $10.98M 12.34% 2026-06-30
4 IMC-Chicago, LLC Custodian $10.92M 12.28% 2026-06-30
5 Jane Street Group, LLC Custodian $9.19M 10.33% 2026-06-30
6 Citadel Advisors LLC Custodian $8.20M 9.21% 2026-06-30
7 Jain Global LLC $2.93M 3.30% 2026-06-30
8 Simplex Trading, LLC Custodian $1.77M 1.99% 2026-06-30
9 DRW Securities, LLC $1.13M 1.27% 2026-06-30
10 Pentwater Capital Management LP $591.60K 0.67% 2026-06-30

MDLN Insider Trading (Form 4)

Latest: 2026-10-13
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-10-13 GIC Special Investments Pte Ltd 10%+ Owner Sell (S) −7,816,987 $35.15 -$274.77M EDGAR
2026-10-06 GIC Private Ltd 10%+ Owner Sell (S) −20,678,630 $34.90 -$721.64M EDGAR
2026-08-21 James M Boyle Chief Executive Officer Grant (A) +764,252 RSU — EDGAR
2026-08-21 Stephen L Miller Chief Operating Officer Grant (A) +87,667 RSU — EDGAR
2026-08-17 GIC Private Ltd 10%+ Owner Sell (S) −1,600,000 $35.80 -$57.28M EDGAR
2026-08-11 GIC Private Ltd 10%+ Owner Sell (S) −590,284 $35.58 -$21.00M EDGAR
2026-08-07 GIC Private Ltd 10%+ Owner Sell (S) −2,248,612 $35.56 -$79.97M EDGAR
2026-08-07 Mozart Holdco, Inc. 10%+ Owner Mixed — — EDGAR
2026-06-17 William J Abrams See Remarks Tax (F) −1,308 $36.61 -$47.9K EDGAR
2026-06-17 Michael B Drazin Chief Financial Officer Tax (F) −1,889 $36.61 -$69.2K EDGAR
2026-06-17 James M Boyle Chief Executive Officer Tax (F) −2,370 $36.61 -$86.8K EDGAR
2026-06-17 Amanda H. Laabs Chief Product Officer Tax (F) −1,889 $36.61 -$69.2K EDGAR
2026-06-17 Stephen L Miller Chief Operating Officer Tax (F) −1,889 $36.61 -$69.2K EDGAR
2026-06-17 Christopher P Shryock Chief Human Resources Officer Tax (F) −872 $36.61 -$31.9K EDGAR
2026-06-17 Alexander M. Liberman Chief Legal Officer Tax (F) −872 $36.61 -$31.9K EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.

MDLN Insider Holdings

39 insiders · @ $39.79
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 Mozart Holdco, Inc. 10%+ Owner 233,520,656 $9.29B $0 2 2026-08-07
2 TC Group VII S1, L.L.C. 10%+ Owner 153,673,564 $6.11B $0 1 2026-03-06
3 Carlyle Mozart Coinvestment UNLV Holdco, L.P. 10%+ Owner 152,460,797 $6.07B $0 1 2026-03-06
4 CPEP Circle Holdings L.P. 10%+ Owner 145,924,924 $5.81B -$554.95M 1 2025-12-22
5 Mozart Aggregator II LP 10%+ Owner 142,918,680 $5.69B -$381.91M 1 2025-12-22
6 CP Circle ML-5 Holdco, L.P. 10%+ Owner 127,567,724 $5.08B -$1.07B 1 2026-03-12
7 CPEP GP, LLC 10%+ Owner 127,567,724 $5.08B -$1.07B 1 2026-03-12
8 TC Group Cayman Investment Holdings Sub L.P. 10%+ Owner 127,567,724 $5.08B -$1.07B 1 2026-03-12
9 Carlyle Group Inc. 10%+ Owner 125,454,241 $4.99B -$1.63B 3 2026-03-12
10 Hux Investment Pte. Ltd. 10%+ Owner 118,796,825 $4.73B $75.52M 1 2025-12-22
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.

MDLN Board & Officers

As of SEC filings through Oct 13, 2026

Directors 12

Officers 10

10% owners 57

Changes in the last 10 years (103)
Oct 13, 2026Hux Investment Pte. Ltd. reported in an SEC filing no longer being a 10% owner
Oct 13, 2026GIC Special Investments Pte Ltd reported in an SEC filing no longer being a 10% owner
Oct 13, 2026GIC Private Ltd reported in an SEC filing no longer being a 10% owner
Jun 17, 2026Douglas P Golwas first listed as a 10% owner in an SEC filing
Feb 24, 2026Jessi L Corcoran became Principal Accounting Officer
Feb 13, 2026CP Circle Holdings, L.P. reported in an SEC filing no longer being a 10% owner
Feb 11, 2026Mozart Aggregator UNLV Holdco L.P. became a 10% owner
Feb 11, 2026Mozart Aggregator II UNLV Holdco L.P. became a 10% owner
Feb 11, 2026Carlyle Mozart Coinvestment UNLV Holdco, L.P. became a 10% owner
Feb 11, 2026CP Circle UNLV Holdco, L.P. became a 10% owner
Jan 21, 2026TC Group VIII, L.P. reported in an SEC filing no longer being a 10% owner
Jan 21, 2026TC Group VIII, L.L.C. reported in an SEC filing no longer being a 10% owner
Jan 21, 2026TC Group VII Lux GP, S.a.r.l. reported in an SEC filing no longer being a 10% owner
Jan 21, 2026CP VIII Circle Holdings, L.P. reported in an SEC filing no longer being a 10% owner
Jan 21, 2026CP VIII Circle AIF Holdings, S.C.Sp. reported in an SEC filing no longer being a 10% owner
Jan 21, 2026CP VII Circle Holdings-A, L.P. reported in an SEC filing no longer being a 10% owner
Jan 21, 2026CP VII Circle Holdings, L.P. reported in an SEC filing no longer being a 10% owner
Jan 21, 2026CP VII Circle AIF Holdings, S.C.Sp. reported in an SEC filing no longer being a 10% owner
Jan 16, 2026TC Group VII, L.P. became a 10% owner
Jan 16, 2026TC Group VII, L.L.C. became a 10% owner
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.

MDLN Proposed Insider Sales (Form 144)

Latest: 2026-06-16
Last 30d: 0 filings  ·  Last 90d: 0 filings

What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.

How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.

10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.

"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.

Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.

Filed Filer Role Shares Notice Value Planned Sale Broker Plan Link
2026-06-16 Douglas Golwas Officer 100,000 $3.65M 2026-06-16 Merrill Lynch 10b5-1 EDGAR
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed. Market-wide feed: Planned sales (Form 144).
Recent SEC Filings
Latest: 2026-06-02
Current reports — material events the company must disclose within 4 business days (earnings releases, M&A, executive changes, etc.).
Filing Date Accession Link
2026-06-02 0001193125-26-252557 EDGAR
2026-05-06 0002046386-26-000022 EDGAR
2026-02-25 0002046386-26-000007 EDGAR
2025-12-22 0001193125-25-328884 EDGAR
Annual report — audited financial statements, MD&A, risk factors. Filed 60–90 days after fiscal year-end.
Filing Date Accession Link
2026-02-25 0002046386-26-000009 EDGAR
Quarterly report — unaudited financials and MD&A. Filed 40–45 days after each of the first three fiscal quarters.
Filing Date Accession Link
2026-05-06 0002046386-26-000026 EDGAR
ETF Holders
101 ETFs hold MDLN
25 shown · $2.02B total exposure · 0.10% AUM-weighted avg weight
# ETF Provider Weight $ Exposure ETF AUM As Of
1 VTI Vanguard Morningstar Total Stock Market ETF Vanguard 0.03% $628.6M — 2026-09-30
2 VO Vanguard Morningstar Mid-Cap ETF Vanguard 0.20% $423.7M — 2026-09-30
3 VXF Vanguard Extended Market ETF Vanguard 0.21% $195.5M — 2026-09-30
4 VTV Vanguard Morningstar Value ETF Vanguard 0.08% $188.5M — 2026-09-30
5 VOE Vanguard Morningstar Mid-Cap Value ETF Vanguard 0.34% $123.5M — 2026-09-30
6 IWR iShares Russell Mid-Cap ETF iShares (BlackRock) 0.13% $77.2M $56.8B 2026-11-04
7 CGUS Capital Group Core Equity ETF Capitalgroup 0.54% $66.8M $12.4B 2026-11-04
8 IWD iShares Russell 1000 Value ETF iShares (BlackRock) 0.05% $39.7M $83.3B 2026-11-04
9 VHT Vanguard Health Care ETF Vanguard 0.18% $39.4M — 2026-09-30
10 ITOT iShares Core S&P Total U.S. Stock Market ETF iShares (BlackRock) 0.03% $26.2M $92.8B 2026-11-04
11 IWS iShares Russell Mid-Cap Value ETF iShares (BlackRock) 0.17% $26.0M $15.2B 2026-11-04
12 VV Vanguard Morningstar Large-Cap ETF Vanguard 0.03% $23.3M — 2026-09-30
13 QQQJ Invesco NASDAQ Next Gen 100 ETF Invesco 1.77% $21.1M — 2026-11-04
14 CGMM Capital Group U.S. Small and Mid Cap ETF Capitalgroup 0.57% $21.0M $3.7B 2026-11-04
15 FPX First Trust US Equity Opportunities ETF First Trust 1.24% $16.7M $1.3B 2026-11-04
16 SCHX Schwab U.S. Large-Cap ETF Nport 0.02% $15.6M — 2026-05-31
17 VT Vanguard Total World Stock ETF Vanguard 0.01% $13.5M — 2026-09-30
18 IYH iShares U.S. Healthcare ETF iShares (BlackRock) 0.26% $12.5M $4.7B 2026-11-04
19 IWB iShares Russell 1000 ETF iShares (BlackRock) 0.03% $12.4M $46.4B 2026-11-04
20 VONV Vanguard Russell 1000 Value ETF Vanguard 0.04% $10.0M — 2026-09-30
21 IMCG iShares Morningstar Mid-Cap Growth ETF iShares (BlackRock) 0.22% $9.1M $3.9B 2026-11-04
22 IPO Renaissance IPO ETF Nport 4.97% $9.0M — 2026-06-30
23 SCHB Schwab U.S. Broad Market ETF Nport 0.02% $8.7M — 2026-05-31
24 ONEQ Fidelity Nasdaq Composite Index ETF Fidelity 0.08% $8.3M $10.6B 2026-11-04
25 FSMD Fidelity Small-Mid Multifactor ETF Fidelity 0.33% $8.2M $2.5B 2026-11-04
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

Trailing P/E
0.00
TTM Diluted EPS
$333000.23
TTM Revenue
$21.92B
TTM Net Income
$522.00M
TTM Op. Cash Flow
—
Quarterly figures (3 quarters)
QuarterPeriod EndRevenueNet IncomeDiluted EPSOp. Cash Flow
Q2 '262026-06-27$7.68B$60.00M$0.07$715.00M
Q1 '262026-03-28$7.35B$129.00M$0.16$412.00M
Q4 '252025-12-31————
Q2 2026 • period ending 2026-06-27 • filed 2026-08-05
Valuation

Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.

Price Multiples
  • P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
  • P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
  • P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
  • EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
  • EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
  • ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
  • ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
  • Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
  • FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
  • Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
  • Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
  • Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
  • Multiples expanding while earnings are flat = sentiment-driven rally.
  • Multiples compressing while earnings grow = value coming from fundamentals.
P/E
0.00
P/B
1.30
P/S
1.13
EV/EBITDA
15.80
EV/Sales
1.60
ROE
2.7%
ROA
1.3%
Div Yield
0.00%
FCF Yield
—
Debt/Equity
0.66
Current Ratio
—
Market Cap
$24.84B
as of 2026-11-06
Short Interest & Float

Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.

Metric definitions
  • Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
  • SI % of Float — short interest / free float. The key crowding metric.
  • Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
  • Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
  • Free Float — shares available for public trading (total shares minus insider / restricted).
  • Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
  • SI % of Float < 5% — typical, no particular signal.
  • 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
  • 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
  • >30% — extreme; borrow is likely expensive and squeeze risk is material.
  • Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
  • Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
  • A sudden drop in SI after a rally may indicate a squeeze in progress.

Short interest is reported mid-month and end-of-month; short volume is daily.

Short Interest
40.82M
SI % of Float
13.25%
Days to Cover
5.38
Short Vol Ratio
49.8%
Free Float
308.13M
Float %
35.1%
Short interest 2026-10-15 • Short volume 2026-11-05 • Float 2026-10-09